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Infectious Disease

Legionnaires' Disease, A Rising Occurrence in the United States
Jennifer Harklerode, Olivia Henton, Myranda Smith, Rebecca Worden, Andrew Roecker, PharmD '00, Pharm D, BCPS

!Abstract
ILegionella pneumophila, a microscopic bacterium usually
/responsible for a number of illnesses and fatalities, can elimi/nate a local population, a region or even a nation. In 1976, L.
Jpneumophila was first discovered due to a number of cases
!presenting with pneumonia-like symptoms. These cases oc1curred in an isolated population attending an American Legion convention in Philadelphia, Pennsylvania, therefore
llending to the name Legionella. Usually found in aquatic en!vironments such as lakes, streams, cooling towers, air condiltioning systems and hot tubs, its ability to thrive in artificial
/and natural environments makes it an ideal bacterium. L.
lpneumophila can be transmitted via inhaling aerosols that
/contain the pathogen. After inhalation, the alveolar macrophages phagocytize the pathogen which then serves as its
host
Virulence factors such as lipopolysaccharides (LPS), are
l
1one way the pathogen causes infection, however it can also
/utilize heat shock protein and surface antigens. Usually with
!Legionnaires' disease the physical symptoms consist of high
!fever, malaise, muscle aches, rigors, confusion, headache and
/diarrhea which categorizes this pathogen as causing an atyplical pneumonia. Since L. pneumophila may be associated
lwith travel-related infections, it is hard to track and isolate
/travel-associated incident clusters because the symptoms
Jpresent themselves after returning from travel. In regard to
/diagnosis, this disease has five available techniques to conlfirm that the patient is in fact positive for L. pneumophila.
!Programs such as the Environmental Legionella Isolation
Techniques Evaluation Program (ELITE) have been started
!by the Centers for Disease Control and Prevention (CDC) in
1order to decrease outbreak incidences. Additionally, the cur/rent recommendations for the management of Legionnaires'
!disease adapted from the CDC have been summarized into a
!flow chart which may help clinical decisions in the treatment
1of this disease.
1
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Introduction
Legionnaires' disease, or Legionellosis, was first identified in
1976 when an onslaught of pneumonia-like symptoms began
in a group of individuals in attendance at an American Legion
convention in Philadelphia.1 Since its first documented manifestation, Legionnaires' disease has remained relatively
dormant. Recently, however, the respirato:ry illness has returned to the spotlight as its abnormal instances of infection
have been thoroughly covered by the news to alert the public. In July 2015, an outbreak of Legionnaires' disease in the
Spring 2016 Volume 7, Issue 2

South Bronx of New York occurred.2 Investigation of this recent outbreak has allowed scientists to trace the pathogen to
its origin at the Opera House Hotel in the South Bronx. The
same strain of bacteria responsible for the outbreak of Legionnaires' disease was found on the cooling towers of the
hotel. This was an overlooked location for disinfection and
may be the reason behind the reoccurrence of the disease.
Potential sources of Legionnaires' disease are often undetected until the disease manifests itself in symptomatic infected
individuals. Furthermore, because patients present with fever, cough and diarrhea, symptoms that are common among
many conditions, the disease presentation does not often
provide a differential diagnosis.3 Laborato:ry diagnostics are
utilized to confirm a case of Legionnaires' disease. The condition is classified as a notifiable disease by the Centers for
Disease Control and Prevention (CDC) and, therefore, is subject to CDC protocol and intervention in the instance of an
outbreak. Finally, with a recent increase in Legionnaires' disease, new policies have been set forth by the CDC to control
as well as prevent future outbreaks.
Etiology /Transmission
Legionella pneumophila is the causative agent of Legionnaires' disease. The microbe is a small, rod-shaped, gramnegative, aerobic, intracellular bacterium.1 The variations in
antigens that reside on the surface of the bacteria give rise to
variations, or serogroups, of the microbe. Serogroup 1 is
responsible for approximately 79 percent of infections in
humans.4 Many diagnostic tools utilize the prevalence of
serotype 1 as the primary source of infection to determine
whether a patient has Legionnaires' disease or another type
of respiratory infection. L. pneumophila resides in natural, as
well as artificial, aquatic environments such as lakes,
streams, cooling towers and air conditioning systems.s In a
natural environment, the microbes reside as an intracellular
parasite within protozoa.6 The microorganism thrives best in
warm temperatures, at an optimal temperature of 35°C, and
therefore it is prevalent in human synthesized water environments where this temperature is maintained.4 The opportunistic, waterborne pathogen is transmitted via inhalation
of aerosols. The bacterium is able to contaminate an aerosol,
become airborne and easily access the respiratory system of
a potential host. Aerosols are commonly in the form of sprays
or mists. For instance, transmission may occur while an individual is showering. This provides an opportunity for
accidental inhalation. Likewise, an individual may become
infected by inhaling contaminated water. It is also important
to note that this particular pathogen is not transmitted from
person to person. A droplet expelled from an infected individual in the form of a sneeze or cough will not transmit the
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pathogen. Therefore, contact with a patient infected by Legionnaires' disease is not dangerous. Furthermore, most
healthy people do not become infected with L. pneumophila
after exposure. Risk factors include ages 50 years or older,
current or former smokers, having a chronic lung disease,
weakened immune system from diseases like cancer, diabetes, or kidney failure, and taking medications that suppress
the immune system.7
The incidence of Legionnaires' disease in the United States
has increased greatly since 1998. This may be attributed to a
rise in the number of individuals in close proximity to contaminated water sources that have not been properly sanitized.B The increase, however, may also be due to greater
access to diagnostic testing or an increase in the number of
immunocompromised or at-risk individuals. This includes
the elderly and those with weakened immune systems or an
underlying illness.9
Pathophysiology
Once inhaled, the pathogen is phagocytized by alveolar macrophages.to Attachment and entrance into the immune cells
is thought to be complement independent and facilitated by
the presence of pili. The microbe possesses the ability to escape an immune response by preventing the formation of the
phagolysosome utilizing a type 4 secretion system. Therefore, the immune function of the macrophage is disabled. The
intracellular bacterium then replicates depending on iron
levels and the success of its various virulence factors.
The virulence factors contributing to the body's response to a
L. pneumophila infection are key elements in the bacterium's
ability to enact an immune response. For example, lipopolysaccharide (LPS), heat-shock proteins as well as other surface proteins serve as antigens, which are common to all
gram-negative bacteria.11 Lipopolysaccharide is an endotoxin
that signals the macrophage to release different proinflammatory cytokines that produce an immune response.
The cytokines that trigger the inflammatory response include
tumor necrosis factor alpha (TNF-a.) and interleukin-1 (IL-1).
T-lymphocytes target heat-shock proteins and produce antibodies in response to their presence to promote the immune
response. Furthermore, fluid extravasation is a characteristic
of this immune response. When the response is signaled
within the lung, fluid can occupy the air spaces thus causing
pneumonia in progressive cases of Legionnaires' disease.
Finally, once the bacterium has completed its replication process, it can initiate apoptosis or necrosis of the macrophage.
New bacteria are then released to infect other cells of the
immune system to further its infective process.
Signs/Symptoms
L. pneumophila is classified as an atypical pneumonia.12 Presented symptoms, radiograph or x-ray results, and response
to certain antibiotics may differ from typical bacteria that
cause pneumonia by Streptococcus pneumoniae. Physical
symptoms that are commonly observed in patients include
high fever, malaise, muscle aches, rigors, confusion, headache
and diarrhea.12,13 These symptoms may be followed by a
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nonproductive cough and shortness of breath. Symptoms
usually present two to 10 days following exposure to the bacteria. However, patients should still be monitored for two
weeks following exposure. Legionnaires' disease is also usually associated with hospital-acquired pneumonia and travel.
Association with travel has been reported during the incubation period for more than 20 percent of cases reported to the
CDC.7 Symptoms often do not present until after the person
has returned from traveling from the source of infection,
which makes detection of travel-associated clusters difficult.
Diagnosis
If an individual is suspected of having Legionnaires' disease,
confirmation should be made with diagnostic testing. There
are five available techniques for the diagnosis of Legionnaires' disease.7 A urine antigen assay along with a culture of
respiratory secretions is the preferred diagnosis method because both tests are 100 percent specific. Urine antigen assay
allows for rapid, same day results but only tests for L. pneumophilia serogroup 1. Respiratory cultures can take more
than five days to provide a result but allow for comparison of
clinical and environmental samples. Cultures may be affected
by antibiotic therapies and must be obtained as soon as possible after a suspected diagnosis. Additionally, cultures detect all species and serogroups of the bacteria. The following
chart adapted from the CDC classifies the advantages and
disadvantages for each diagnostic test (Table 1).
After confirmation of Legionnaires' disease, steps must be
taken to find the source of infection and inform the proper
officials. Figure 1 provides a breakdown of the steps to diagnose a case of Legionnaires' disease.14

Recent Outbreaks
The World Health Organization (WHO) defines a disease outbreak as an "occurrence of cases of disease in excess of what
would normally be expected in a defined community, geographical area or season."ts These occurrences may be confined to one area or may span entire countries while lasting
anywhere from days to several years. The CDC mentions that
when two or more L. pneumophila exposed individuals occur
at the same time and place and become sick as a result, a Legionellosis outbreak has occurred.7

In 2008, there were eight confirmed cases of a Legionnaires'
disease outbreak at Saint Peter's University Hospital in New
Jersey, resulting in three fatalities.16-10 All those infected had
other underlying diseases that made them more susceptible
to the L. pneumophila that was traced back to the hospital's
water system.
The Veteran Affairs Pittsburgh Healthcare System reported
another L. pneumophila outbreak in October 2012.19 The
CDC identified a total of 21 cases of Legionnaires' disease in
this outbreak. This total was broken down into five definite
and 16 probable health care-associated cases. There were
five fatalities resulting from this outbreak, all within 30 days
of a positive diagnostic test.
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Table 1. Diagnostic Tests for Legionnaires' Disease.12
Adapted from Centers for Disease Control and Prevention [Internet]. Atlanta (GA): U.S. Department of Health & Human Services. Atypical
Pneumonia; [updated 2014 Feb 7; cited 2015 Nov 7]. Available from:www.cdc.gov/pneumonia/atypical/.
Test

Advantages

Disadvantages

Culture

•

•
•

•

Clinical and environmental isolates can
be compared
Detects all species and serogroups
100% specific

•

•

Rapid (same day results)

•

•
Urine Antigen

•

•
Serology

Direct
Fluorescent
Antibody (DFA)
Polymerase Chain
Reaction (PCR)

•

Technically difficult
Slow (>5 days to grow)
Sensitivity high dependent on technical skill
May be affected by antibiotic treatment
Only 100% specific for L. pneumophilia serogroup
1 (Lpl)
0
Lpl may account for up to 80% of cases
Does not allow for molecular comparison to environmental isolates

•

Less affected by antibiotic treatment

•

80-90% sensitive; 99% specific

•

•

25-75% sensitive

•

Can be performed on pathologic specimens
> 95% specific

•

Rapid

•

Assays vary by laboratory and are not FDAapproved

•

Must have paired sera
5-10% of population has titer 1 > 256 (no discrimination between cases of Legionnaires' disease and other causes of community-acquired
pneumonia)

Figure 1. Process for Suspected Cases of Legionnaires' Disease.14
Adapted from : Bartram J, Chartier Y, Lee JV, Bond K, Surman-Lee S. Legionella and the prevention oflegionellosis [Internet]. World Health
Organization; 2007. Figure 9-1 p.143 [cited 2015 Nov 7]. Available from: www.who.int/water_sanitation_health/emerging/legionella.pdf.

Suspect case
of
Legionnaires'
Disease

Health-care acquired:
Report to local
health officials->
obtain 2 week
exposure history->
report case to CDC

Search for other cases;
Review hospital maintenance
and risk management records

Positive result
Community acquired:

ConfirmL

Identify possible sources->
Find source of
.,._ _ _"4 review maintenance records of
infection
thesesources->checkfor
related cases

Pneumophila by
urine, culture or
serolo
Negative results

No further action

Trave assodated:
obtain details of travel ->
re Ort info to CDC
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One of the largest outbreaks occurred in July 2015 in the
South Bronx in New York City. 20 The source of contamination
was found to be a cooling tower located on top of the Opera
House Hotel. In this outbreak, 120 people were infected resulting in 12 deaths.
The most recent cases occurred in August 2015. The Illinois
Department of Veterans' Affairs announced eight confirmed
cases with no related fatalities.2 1 In this same time period, an
outbreak also occurred in the San Quentin State Prison
located in California where there were six confirmed cases.22
Furthermore, a woman died after diagnosis in University
Hospitals Case Medical Center in Cleveland, Ohio.23 A month
later in Cleveland, Ohio, an employee at the NASA Glenn Research Center was diagnosed with Legionnaires' disease. Although there was no direct CDC response in these cases, the
respective state health departments were involved. However,
in some situations the CDC protocols for treating L. pneumophila were used.23

Response from Centers for Disease Control and Prevention
In response to numerous outbreaks of L. pneumophila, the
CDC started the Environmental L. pneumophila isolation
Techniques Evaluation Program (ELlTE). its goal is to certify
labs that are collecting and testing water samples for Legionella. However, even with the ELITE certification, a lab is
not automatically certified to eliminate the bacteria from the
water. The CDC recommends that every outbreak should be
treated independent from other cases. 24
The CDC has kept a close eye on areas of natural disaster or
warfare. These events lead to water systems becoming stagnant at room temperature. Since L. pneumophila bacterial
growth thrives in temperatures of 35°C, these water systems
become the ideal areas for Legionnaires' disease. The CDC
has teamed up with the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE®) to compile guidelines for treating and eradicating affected water
systems. The final report, "ASHRAE Guideline 12-2000Minimizing the Risk of Legionellosis Associated with Building
Water Systems," has served as the standard to eradicate L.
pneumophila in affected water systems.zs. 26

Management of Disease
Current general recommendations for the management of
Legionnaires' disease have been outlined in the flowchart in
Figure 2.27 These include the early diagnosis, prompt treatment with appropriate antibiotics and management of any of
the possible respiratory, renal or CNS complications. This is
key in identifying and managing Legionnaires' disease effectively to predict the best patient outcomes. Patients presenting with community-acquired pneumonia (CAP) should be
tested for Legionnaires' disease if they have failed a course of
antibiotics for CAP, have severe symptoms requiring intensive care, are immunocompromised, are from an environment with a Legionella outbreak or have a travel history
within two weeks of the onset of symptoms.
Jn cases of community-acquired pneumonia, the treatment
guidelines are established via the Infectious Diseases Society
of America and American Thoracic Society.2s These consensus guidelines provide information on the diagnosis, empirical therapy and focused management of both inpatient and
outpatient situations. For patients who are in the [CU, recommendations for empiric antibiotics are a beta-lactam in addition to azithromycin or respiratory fluoroquinolone (ciprofloxacin, levofloxacin, moxifloxacin). Once the L. pneumophila is confirmed, the beta-lactam is no longer needed. Most
patients recover from fever within three to five days, but
therapy is continued for 10 to 14 days (five to 10 days for
azithromycin), based on clinical stability (Table 2). In immunocompromised patients, therapy may be continued for
as long as 21 days.14

Conclusion
Legionnaires' disease management, treatment and eradication come to the spotlight when outbreaks occur. Recent
outbreaks throughout the United States have prompted the
scientific community to learn more about how to earlier
identify and fight Legionnaires' disease. With the use of programs like ELITE from the CDC and effective treatment protocols, health care professionals can effectively eradicate
Legionnaires' disease while providing the best care to their
patients.

Figure 2. General Recommendations for Legionellosis Management.27
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Table 2. Criteria for Clinical Stability.zs
Patients should have no more than one of the following before discontinuation of antibiotics:
0
Temperature s 37.8° C
Heart rate s 100 beats/min
Respiratory rates 24 breaths/min
0
Systolic blood pressure ~ 90mm Hg
Arterial oxygen saturation 90% or p02 60mm Hg on room air
Normal mental status
0

0
0

Mandell LA. Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/ American Thoracic
Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin lnfec Dis. 2007;44(Suppl 2):S27-S72.
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